sb 203580 has been researched along with sodium azide in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (sodium azide) | Trials (sodium azide) | Recent Studies (post-2010) (sodium azide) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 2,018 | 5 | 323 |
Protein | Taxonomy | sb 203580 (IC50) | sodium azide (IC50) |
---|---|---|---|
Integrase | Human immunodeficiency virus 1 | 1.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Desaki, M; Kato, J; Kikuchi, K; Kohyama, T; Nagase, T; Okazaki, H; Rennard, SI; Takami, K; Takizawa, H; Yamauchi, Y | 1 |
1 other study(ies) available for sb 203580 and sodium azide
Article | Year |
---|---|
C-reactive protein modulates human lung fibroblast migration.
Topics: C-Reactive Protein; Cell Migration Assays; Cell Migration Inhibition; Cells, Cultured; Chemotaxis; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Fibronectins; Humans; Imidazoles; Lipopolysaccharides; Lung; p38 Mitogen-Activated Protein Kinases; Pyridines; Sodium Azide | 2009 |